Non-small cell lung cancer: from targeted therapy to tailored therapy

Expert Opin Pharmacother. 2012 Sep;13(13):1817-9. doi: 10.1517/14656566.2012.707645. Epub 2012 Jul 18.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Clinical Trials, Phase III as Topic
  • Drug Delivery Systems
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Survival Rate

Substances

  • Antineoplastic Agents